2018 Q1 Form 10-Q Financial Statement

#000156459018012666 Filed on May 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q1
Revenue $700.0K $704.0K $743.0K
YoY Change -5.79% 4.14% 100.81%
Cost Of Revenue $147.0K $170.0K $219.0K
YoY Change -32.88% -5.56% 97.3%
Gross Profit $555.0K $530.0K $524.0K
YoY Change 5.92% 6.0% 102.32%
Gross Profit Margin 79.29% 75.28% 70.52%
Selling, General & Admin $2.366M $1.880M $2.415M
YoY Change -2.03% -21.99% 1.6%
% of Gross Profit 426.31% 354.72% 460.88%
Research & Development $5.692M $3.380M $2.321M
YoY Change 145.24% 36.84% 73.21%
% of Gross Profit 1025.59% 637.74% 442.94%
Depreciation & Amortization $120.0K $110.0K $74.00K
YoY Change 62.16% 37.5% -14.94%
% of Gross Profit 21.62% 20.75% 14.12%
Operating Expenses $8.058M $5.254M $4.736M
YoY Change 70.14% 7.62% 27.28%
Operating Profit -$7.503M -$4.725M -$4.212M
YoY Change 78.13% 7.8% 21.66%
Interest Expense -$2.000K $12.50M -$8.366M
YoY Change -99.98% 22.43% -167420.0%
% of Operating Profit
Other Income/Expense, Net -$5.000K -$50.00K $8.000K
YoY Change -162.5% -99.65% -128.57%
Pretax Income $7.190M -$19.24M -$11.33M
YoY Change -163.46% 126.62% 525.97%
Income Tax -$140.0K
% Of Pretax Income
Net Earnings $7.185M -$19.25M -$11.33M
YoY Change -163.4% 126.8% 525.04%
Net Earnings / Revenue 1026.43% -2733.81% -1525.17%
Basic Earnings Per Share $10.91 -$0.75 -$45.70K
Diluted Earnings Per Share $10.91 -$265.9B -$45.70K
COMMON SHARES
Basic Shares Outstanding 658.9K 248.0
Diluted Shares Outstanding 658.9K 248.0

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.030M $4.000M $6.400M
YoY Change -68.28% -9.3% -32.98%
Cash & Equivalents $3.116M $3.999M $6.400M
Short-Term Investments
Other Short-Term Assets $1.610M $2.030M $22.31M
YoY Change -92.78% -92.92% 2435.23%
Inventory $1.280M $1.248M $870.0K
Prepaid Expenses
Receivables $280.0K $317.0K $390.0K
Other Receivables $30.00K $0.00 $0.00
Total Short-Term Assets $5.230M $7.589M $29.97M
YoY Change -82.55% -77.78% 161.52%
LONG-TERM ASSETS
Property, Plant & Equipment $1.190M $1.298M $1.070M
YoY Change 11.21% 19.85% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.190M $1.298M $1.070M
YoY Change 11.21% 19.85% 0.0%
TOTAL ASSETS
Total Short-Term Assets $5.230M $7.589M $29.97M
Total Long-Term Assets $1.190M $1.298M $1.070M
Total Assets $6.420M $8.887M $31.04M
YoY Change -79.32% -74.78% 147.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.580M $3.846M $700.0K
YoY Change 554.29% 547.47% 438.46%
Accrued Expenses $1.920M $3.408M $1.680M
YoY Change 14.29% 0.03% 12.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $9.290M
YoY Change -100.0%
Total Short-Term Liabilities $12.28M $7.814M $31.05M
YoY Change -60.47% -78.35% 696.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $345.0K $395.0K $545.0K
YoY Change -36.7% -34.6% -29.22%
Total Long-Term Liabilities $345.0K $395.0K $545.0K
YoY Change -36.7% -34.6% -29.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.28M $7.814M $31.05M
Total Long-Term Liabilities $345.0K $395.0K $545.0K
Total Liabilities $12.62M $8.209M $31.63M
YoY Change -60.09% -77.65% 577.19%
SHAREHOLDERS EQUITY
Retained Earnings -$317.6M -$324.8M -$290.5M
YoY Change 9.34% 16.35%
Common Stock $9.000K $3.000K $1.186M
YoY Change -99.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K $51.00K
YoY Change 0.0% 0.0%
Treasury Stock Shares $1.00 $1.00 $110.00
Shareholders Equity -$6.205M $678.0K -$586.0K
YoY Change
Total Liabilities & Shareholders Equity $6.418M $8.887M $31.04M
YoY Change -79.32% -74.78% 147.72%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q1
OPERATING ACTIVITIES
Net Income $7.185M -$19.25M -$11.33M
YoY Change -163.4% 126.8% 525.04%
Depreciation, Depletion And Amortization $120.0K $110.0K $74.00K
YoY Change 62.16% 37.5% -14.94%
Cash From Operating Activities -$6.443M -$3.740M -$3.820M
YoY Change 68.66% 3.6% 0.0%
INVESTING ACTIVITIES
Capital Expenditures $6.000K -$150.0K $58.00K
YoY Change -89.66% 1400.0% 286.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$6.000K -$150.0K -$60.00K
YoY Change -90.0% 650.0% 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.253M -1.790M 6.090M
YoY Change -30.16% -140.04% 690.91%
NET CHANGE
Cash From Operating Activities -6.443M -3.740M -3.820M
Cash From Investing Activities -6.000K -150.0K -60.00K
Cash From Financing Activities 4.253M -1.790M 6.090M
Net Change In Cash -2.208M -5.680M 2.210M
YoY Change -199.91% -776.19% -171.99%
FREE CASH FLOW
Cash From Operating Activities -$6.443M -$3.740M -$3.820M
Capital Expenditures $6.000K -$150.0K $58.00K
Free Cash Flow -$6.449M -$3.590M -$3.878M
YoY Change 66.3% -0.28% 1.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4169000
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
560000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12275000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7814000
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
345000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
395000
CY2018Q1 us-gaap Liabilities
Liabilities
12620000
CY2017Q4 us-gaap Liabilities
Liabilities
8209000
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
9000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
311477000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325517000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-317645000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-324832000
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
42000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-6202000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
678000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6418000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8887000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
896995
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228140
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
896994
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228139
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
147000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
219000
CY2018Q1 us-gaap Gross Profit
GrossProfit
555000
CY2017Q1 us-gaap Gross Profit
GrossProfit
524000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2366000
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2415000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5692000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2321000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
8058000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4736000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7503000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4212000
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14697000
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1238000
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2000
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8366000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
7187000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-11332000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7153000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11354000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.91
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-45695
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.91
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-45695
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
658893
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
248
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
658893
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248
CY2017Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:350
CY2017Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0029
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4252000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18306000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-34000
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-152000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
828000
CY2018Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-50000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6443000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6000
CY2018Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
238000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4253000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4491000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-12000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1970000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4409000
CY2018Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
12210000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
18306000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0
CY2017Q4 dcth Value Added Tax And Goods And Services Tax Receivable Current
ValueAddedTaxAndGoodsAndServicesTaxReceivableCurrent
29000
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
49000
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2018Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
134000
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
130000
CY2018Q1 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2017Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5191000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5174000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4003000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3876000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
738000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
869000
CY2018Q1 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1603000
CY2018Q1 dcth Number Of Distribution Contracts
NumberOfDistributionContracts
1
CY2017Q4 dcth Financing Costs Current
FinancingCostsCurrent
70000
CY2018Q1 dcth Value Added Tax And Goods And Services Tax Receivable Current
ValueAddedTaxAndGoodsAndServicesTaxReceivableCurrent
34000
CY2017Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1124000
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
95000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
221000
CY2018Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
197000
CY2017Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
209000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
893000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
985000
CY2018Q1 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
424000
CY2018Q1 dcth Number Of Pre Funded Warrants
NumberOfPreFundedWarrants
76000
CY2018Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4200000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
560000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
14697000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4169000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1014041
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q1 dcth Tax Cuts And Jobs Act Of2017 Tax Effect Accounting Complete
TaxCutsAndJobsActOf2017TaxEffectAccountingComplete
false
CY2018Q1 dcth Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Assets Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetsProvisionalIncomeTaxExpenseBenefit
143500000
CY2018Q1 dcth Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Liability
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalLiability
0

Files In Submission

Name View Source Status
0001564590-18-012666-index-headers.html Edgar Link pending
0001564590-18-012666-index.html Edgar Link pending
0001564590-18-012666.txt Edgar Link pending
0001564590-18-012666-xbrl.zip Edgar Link pending
dcth-10q_20180331.htm Edgar Link pending
dcth-20180331.xml Edgar Link completed
dcth-20180331.xsd Edgar Link pending
dcth-20180331_cal.xml Edgar Link unprocessable
dcth-20180331_def.xml Edgar Link unprocessable
dcth-20180331_lab.xml Edgar Link unprocessable
dcth-20180331_pre.xml Edgar Link unprocessable
dcth-ex311_8.htm Edgar Link pending
dcth-ex312_7.htm Edgar Link pending
dcth-ex321_6.htm Edgar Link pending
dcth-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending